Np mrd loader

Record Information
Version1.0
Created at2022-09-09 06:58:09 UTC
Updated at2022-09-09 06:58:10 UTC
NP-MRD IDNP0280918
Secondary Accession NumbersNone
Natural Product Identification
Common Name(1r,9r)-3,5,14-trihydroxy-13-methoxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-8-oxatetracyclo[7.7.0.0²,⁷.0¹¹,¹⁶]hexadeca-2,4,6,11(16),12,14-hexaen-10-one
Description(1R,9R)-3,5,14-trihydroxy-13-methoxy-9-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-8-oxatetracyclo[7.7.0.0²,⁷.0¹¹,¹⁶]Hexadeca-2,4,6,11,13,15-hexaen-10-one belongs to the class of organic compounds known as indanones. Indanones are compounds containing an indane ring bearing a ketone group. (1r,9r)-3,5,14-trihydroxy-13-methoxy-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-8-oxatetracyclo[7.7.0.0²,⁷.0¹¹,¹⁶]hexadeca-2,4,6,11(16),12,14-hexaen-10-one is found in Kaempferia parviflora. It was first documented in 2022 (PMID: 36113990). Based on a literature review a significant number of articles have been published on (1R,9R)-3,5,14-trihydroxy-13-methoxy-9-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-8-oxatetracyclo[7.7.0.0²,⁷.0¹¹,¹⁶]Hexadeca-2,4,6,11,13,15-hexaen-10-one (PMID: 36113989) (PMID: 36113988) (PMID: 36113987) (PMID: 36113986) (PMID: 36113984) (PMID: 36113985).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC28H32O16
Average Mass624.5480 Da
Monoisotopic Mass624.16903 Da
IUPAC Name(1R,9R)-3,5,14-trihydroxy-13-methoxy-9-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-8-oxatetracyclo[7.7.0.0^{2,7}.0^{11,16}]hexadeca-2,4,6,11(16),12,14-hexaen-10-one
Traditional Name(1R,9R)-3,5,14-trihydroxy-13-methoxy-9-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-8-oxatetracyclo[7.7.0.0^{2,7}.0^{11,16}]hexadeca-2,4,6,11(16),12,14-hexaen-10-one
CAS Registry NumberNot Available
SMILES
COC1=CC2=C(C=C1O)[C@@H]1C3=C(O)C=C(O)C=C3O[C@]1(O[C@@H]1O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]1O)C2=O
InChI Identifier
InChI=1S/C28H32O16/c1-8-19(32)21(34)23(36)26(41-8)40-7-16-20(33)22(35)24(37)27(42-16)44-28-18(17-13(31)3-9(29)4-15(17)43-28)10-5-12(30)14(39-2)6-11(10)25(28)38/h3-6,8,16,18-24,26-27,29-37H,7H2,1-2H3/t8-,16+,18+,19-,20+,21+,22-,23+,24+,26+,27-,28+/m0/s1
InChI KeyDXOKOFWCEQXYQM-DNWFQKTLSA-N
Experimental Spectra
Not Available
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 25 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 252 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 50 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 75 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 101 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 126 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 151 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 176 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 226 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, H2O, predicted)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Kaempferia parvifloraLOTUS Database
Chemical Taxonomy
Description Belongs to the class of organic compounds known as indanones. Indanones are compounds containing an indane ring bearing a ketone group.
KingdomOrganic compounds
Super ClassBenzenoids
ClassIndanes
Sub ClassIndanones
Direct ParentIndanones
Alternative Parents
Substituents
  • Disaccharide
  • Glycosyl compound
  • Indanone
  • O-glycosyl compound
  • Coumaran
  • Anisole
  • Aryl alkyl ketone
  • Aryl ketone
  • 1-hydroxy-4-unsubstituted benzenoid
  • 1-hydroxy-2-unsubstituted benzenoid
  • Alkyl aryl ether
  • Ketal
  • Oxane
  • Secondary alcohol
  • Ketone
  • Acetal
  • Ether
  • Oxacycle
  • Organoheterocyclic compound
  • Polyol
  • Hydrocarbon derivative
  • Alcohol
  • Organic oxygen compound
  • Organic oxide
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-0.89ChemAxon
pKa (Strongest Acidic)7.93ChemAxon
pKa (Strongest Basic)-3.6ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count16ChemAxon
Hydrogen Donor Count9ChemAxon
Polar Surface Area254.52 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity141.27 m³·mol⁻¹ChemAxon
Polarizability60.27 ųChemAxon
Number of Rings6ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound162898565
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Concha-Miranda M, Tang W, Hartmann K, Brecht M: Large-scale mapping of vocalization-related activity in the functionally diverse nuclei in rat posterior brainstem. J Neurosci. 2022 Sep 16. pii: JNEUROSCI.0813-22.2022. doi: 10.1523/JNEUROSCI.0813-22.2022. [PubMed:36113990 ]
  2. Kausto J, Gluschkoff K, Turunen J, Selinheimo S, Peutere L, Vaananen A: Psychotherapy and change in mental health-related work disability: a prospective Finnish population-level register-based study with a quasi-experimental design. J Epidemiol Community Health. 2022 Sep 16. pii: jech-2022-218941. doi: 10.1136/jech-2022-218941. [PubMed:36113989 ]
  3. Meulemans L, Baert Desurmont S, Waill MC, Castelain G, Killian A, Hauchard J, Frebourg T, Coulet F, Martins A, Muleris M, Gaildrat P: Comprehensive RNA and protein functional assessments contribute to the clinical interpretation of MSH2 variants causing in-frame splicing alterations. J Med Genet. 2022 Sep 16. pii: jmg-2022-108576. doi: 10.1136/jmg-2022-108576. [PubMed:36113988 ]
  4. Otsuji S, Nishio Y, Tsujita M, Rio M, Huber C, Anton-Plagaro C, Mizuno S, Kawano Y, Miyatake S, Simon M, van Binsbergen E, van Jaarsveld RH, Matsumoto N, Cormier-Daire V, J Cullen P, Saitoh S, Kato K: Clinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome. J Med Genet. 2022 Sep 16. pii: jmg-2022-108602. doi: 10.1136/jmg-2022-108602. [PubMed:36113987 ]
  5. Crul M, Breukels O: Safe handling of cytostatic drugs: recommendations from independent science. Eur J Hosp Pharm. 2022 Sep 16. pii: ejhpharm-2022-003469. doi: 10.1136/ejhpharm-2022-003469. [PubMed:36113986 ]
  6. Kroshus E, Chrisman SPD, Glang A, Hunt T, Hays R, Lowry S, Peterson A, Garrett K, Ramshaw D, Hafferty K, Kinney E, Manzueta M, Steiner MK, Bollinger BJ, Chiampas G, Rivara FP: Concussion education for youth athletes using Pre-Game Safety Huddles: a cluster-randomised controlled trial. Inj Prev. 2022 Sep 16. pii: ip-2022-044665. doi: 10.1136/ip-2022-044665. [PubMed:36113984 ]
  7. Hwang J, Kelz R: Impact of medical education on patient safety: finding the signal through the noise. BMJ Qual Saf. 2022 Sep 16. pii: bmjqs-2022-015054. doi: 10.1136/bmjqs-2022-015054. [PubMed:36113985 ]
  8. Munoz J, Palacios-Corella M, Gomez IJ, Zajickova L, Pumera M: Synthetic Nanoarchitectonics of Functional Organic-Inorganic 2D Germanane Heterostructures via Click Chemistry. Adv Mater. 2022 Sep 16:e2206382. doi: 10.1002/adma.202206382. [PubMed:36113982 ]
  9. Adolph TE, Zhang J: Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts. Gut. 2022 Sep 16. pii: gutjnl-2021-326575. doi: 10.1136/gutjnl-2021-326575. [PubMed:36113981 ]
  10. Kulkarni AV, Metage CS, Gora BA, Tirumalle S, Rakam K, Satyavadi A, Sharma M, Shaik S, Gujjarlapudi D, Rao PN, Reddy DN: SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis. Gut. 2022 Sep 16. pii: gutjnl-2022-328451. doi: 10.1136/gutjnl-2022-328451. [PubMed:36113980 ]
  11. Rugge M, Genta RM, Malfertheiner P, Graham DY: Steps forward in understanding gastric cancer risk. Gut. 2022 Sep 16. pii: gutjnl-2022-328514. doi: 10.1136/gutjnl-2022-328514. [PubMed:36113979 ]
  12. Rees CJ, Hamilton W: BSG guidelines on faecal immunochemical testing: are they 'FIT' for purpose? Gut. 2022 Sep 16. pii: gutjnl-2022-328201. doi: 10.1136/gutjnl-2022-328201. [PubMed:36113978 ]
  13. Zhang Q, Mao Y, Lin C, Hu M, Wang Y, Lou Y, Kong Q, Zhang J, Li J, Zhang Y, Yang T, Sun X, Yao W, Hua Y, Huang H, Xu M, Wang X, Yu X, Tao W, Liu R, Gao Y, Wang T, Wang J, Wei X, Wu J, Yu Z, Zhang C, Yu C, Bai X, Liang T: Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study. Gut. 2022 Sep 16. pii: gutjnl-2022-327496. doi: 10.1136/gutjnl-2022-327496. [PubMed:36113977 ]
  14. Toresdahl BG, Metzl JD, Kinderknecht J, McElheny K, de Mille P, Quijano B, Fontana MA: Training patterns associated with injury in New York City Marathon runners. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105670. doi: 10.1136/bjsports-2022-105670. [PubMed:36113976 ]
  15. Recchia F, Leung CK, Chin EC, Fong DY, Montero D, Cheng CP, Yau SY, Siu PM: Comparative effectiveness of exercise, antidepressants and their combination in treating non-severe depression: a systematic review and network meta-analysis of randomised controlled trials. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105964. doi: 10.1136/bjsports-2022-105964. [PubMed:36113975 ]
  16. Shimada S, Ikenoue C, Iwashita Y, Miyamoto T: Contributions of the Tokyo 2020 Infectious Diseases Control Centre in curbing SARS-CoV-2 spread during the Olympic and Paralympic Games. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105691. doi: 10.1136/bjsports-2022-105691. [PubMed:36113974 ]
  17. Urhausen AP, Berg B, Oiestad BE, Whittaker JL, Culvenor AG, Crossley KM, Juhl CB, Risberg MA: Measurement properties for muscle strength tests following anterior cruciate ligament and/or meniscus injury: What tests to use and where do we need to go? A systematic review with meta-analyses for the OPTIKNEE consensus. Br J Sports Med. 2022 Sep 16. pii: bjsports-2022-105498. doi: 10.1136/bjsports-2022-105498. [PubMed:36113973 ]
  18. Neves J, Al-Harahsheh ST, Swart K, Shaban S, Hudaib A: Inclusion of persons with disability in sport: part 2 - best practices and policy recommendations from Qatar. Br J Sports Med. 2022 Nov;56(22):1259-1260. doi: 10.1136/bjsports-2022-106225. Epub 2022 Sep 16. [PubMed:36113972 ]
  19. Al-Harahsheh ST, Swart K, Neves J, Shaban S: Inclusion of persons with disability in sport: part 1 - rights and challenges in Qatar. Br J Sports Med. 2022 Nov;56(22):1257-1258. doi: 10.1136/bjsports-2022-106224. Epub 2022 Sep 16. [PubMed:36113971 ]
  20. Jimenez IA, Pool RR, Gabrielson KL: Canine Idiopathic Arteriopathy, Appendicular Bone Infarcts, and Neoplastic Transformation of Bone Infarcts in 108 Dogs (Canis lupus familiaris). Comp Med. 2022 Oct 1;72(5):306-319. doi: 10.30802/AALAS-CM-22-000037. Epub 2022 Sep 16. [PubMed:36113969 ]
  21. LOTUS database [Link]